|
Press Releases |
|
|
|
Tuesday, February 18, 2020 |
|
AIM ImmunoTech Issues Stockholder Update on the Potential Role of Ampligen for Use Against the Wuhan Coronavirus Epidemic |
AIM ImmunoTech (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers, today provided its stockholders with an update on its efforts to develop Ampligen as a protective therapeutic and a vaccine in the new coronavirus epidemic. more info >> |
|
AIM ImmunoTech Issues Stockholder Update on the Potential Role of Ampligen for Use Against the Coronavirus Epidemic |
AIM ImmunoTech (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat immune disorders, viral diseases and multiple types of cancers, today provided its stockholders with an update on its efforts to develop Ampligen as a protective therapeutic and a vaccine in the new coronavirus epidemic. more info >> |
|
Tuesday, February 11, 2020 |
|
AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus |
AIM ImmunoTech Inc. (NYSE American:AIM) today announced the filing of three provisional patent applications related to its drug candidate Ampligen in the company's efforts toward joining the global health community in the fight against the deadly Wuhan coronavirus that has so far infected approximately 40,000 people and killed almost one thousand, primarily in China. more info >> |
|
AIM ImmunoTech提交了三项有关安普利近(R) 的临时专利申请,以用于对抗类似SARS的武汉2019年新型冠状病毒 |
AIM ImmunoTech公司(NYSE-American交易代码:AIM)今天宣布提交了三份临时专利申请,涉及其候选药物安普利近,这是公司加入全球卫生界抗击致命的武汉冠状病毒的努力,该病毒迄今为止已经感染了大约40000人,有近千人死亡,主要集中在中国。 more info >> |
|
AIM ImmunoTech提交了三項有關安普利近(R) 的臨時專利申請,以用於對抗類似SARS的武漢2019年新型冠狀病毒 |
AIM ImmunoTech公司(NYSE-American交易代碼:AIM)今天宣布提交了三份臨時專利申請,涉及其候選藥物安普利近,這是公司加入全球衛生界抗擊致命的武漢冠狀病毒的努力,該病毒迄今為止已經感染了大約40000人,有近千人死亡,主要集中在中國。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
健倍苗苗发布盈喜
May 5, 2024 11:00 HKT/SGT
|
|
|
健倍苗苗發佈盈喜
May 5, 2024 11:00 HKT/SGT
|
|
|
JBM Healthcare Issues Positive Profit Alert
May 5, 2024 11:00 HKT/SGT
|
|
|
Aemetis to Review First Quarter 2024 Financial Results on May 9, 2024
May 4, 2024 01:00 HKT/SGT
|
|
|
Peapack Private Hires Jerry Dominguez as Senior Managing Director
May 4, 2024 01:00 HKT/SGT
|
|
|
UVify Sets New Guinness World Record With 5,293 IFO Drones in Spectacular Aerial Display
May 4, 2024 00:00 HKT/SGT
|
|
|
2024 CAP Consumer Survey Shows Increase in Piracy on Social Media and Messaging Platforms in Asia Pacific
May 3, 2024 20:40 HKT/SGT
|
|
|
SDAI Limited: Positive Outcomes Since New Board took over in June 2023
May 3, 2024 20:00 HKT/SGT
|
|
|
Loop Industries and Ester Industries Ltd. Announce Joint Venture Agreement to Build an Infinite Loop(TM) Manufacturing Facility in India
May 3, 2024 20:00 HKT/SGT
|
|
|
Singapore's top general insurer debuts trading on Asia's leading digital exchange, AltaX
May 3, 2024 10:30 HKT/SGT
|
|
|
Nephros Schedules First Quarter 2024 Financial Results Conference Call
May 3, 2024 08:31 HKT/SGT
|
|
|
Nass Valley Gateway Ltd Announces It Will File Its 2023 EOY Audited Financials by June 28th, 2024, Within the Extension Granted by the BCSC
May 3, 2024 08:26 HKT/SGT
|
|
|
UPDATE: Kaplan Fox Files Class Action to Recover Losses for Investors Who Were Short The Barclays Bank PLC iPath Series B S&P 500 VIX Short-Term Futures ETN (CBOE: VXX) ("VXX")
May 3, 2024 08:05 HKT/SGT
|
|
|
长江电力公布2023年年度业绩 营收利润双增长
May 2, 2024 23:00 HKT/SGT
|
|
|
長江電力公佈2023年年度業績 營收利潤雙增長
May 2, 2024 22:54 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|